75F40122F19011↗

Name: 75F40122F19011: Development and Dissemination of Education Materials on Rare Disease Drug Development
Creator: SpendQuery

DEVELOPMENT AND DISSEMINATION OF EDUCATION MATERIALS ON RARE DISEASE DRUG DEVELOPMENT

Bpa Call · Food and Drug Administration · to Booz Allen Hamilton Inc (UEI JCBMLGPE6Z71) · data as of 2026-09-30

Obligated to date$875.8K2 actions

Current value$1.85Mwith options exercised

Period2022-08-22 → 2025-04-05current end date

What it is

Product or service: Support- Professional: Program Management/Support (PSC R408)
Industry: Administrative Management and General Management Consulting Services (NAICS 541611)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Competition: Full and open competition
Pricing: Firm fixed price
How it was bought: Blanket purchase agreement (BPA) · under 75F40122A00008
Where the work is: Montgomery, MD · district MD-08

Obligations by fiscal year

FY2023$690.8K

FY2024$184.9K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2023-08-24. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2024-09-06	P00002	Supplemental agreement (work within scope)	$184.9K	TO EXTEND PERIOD OF PERFORMANCE FOR 4 MONTHS, ADD ADDITIONAL DELIVERABLES WITHIN THE EXISTING SCOPE OF WORK, AND ADD ADDITIONAL PROJECT MANAGEMENT HOURS TO SUPPORT THE PROJECT.
2023-08-24	P00001	Funding only	$690.8K	DEVELOPMENT AND DISSEMINATION OF EDUCATION MATERIALS ON RARE DISEASE DRUG DEVELOPMENT

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗